In conclusion, our study demonstrated that OMEO exerts anti-colon cancer activity through activation of p38 MAPK signaling, induction of protective autophagy, associated with downregulation of the mTOR/p70S6K pathway, and activation of the extrinsic and intrinsic apoptotic pathway. Here, RPS6KB1 is linked to malignant colon neoplasm.